Would you consider TPO mimetics for chemotherapy induced thrombocytopenia that persists despite dose reductions?
Community PollStarted
Do you use TPO mimetics for chemotherapy induced thrombocytopenia that persists despite dose reductions?
51 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Weill Medical College of Cornell University
Answered on
The reported evidence on using a TPO-RA in chemotherapy-induced thrombocytopenia (CIT) is complicated but this seems like a situation where it is worth trying a TPO-RA. Repeated dose reduction and/or delay is not good for treatment of a cancer in general. It is very important to individualize the ca...
Join for free or sign in to see the full answer